STAGE III PROSTATE CANCER AJCC V7
Clinical trials for STAGE III PROSTATE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test malaria drug combo against tough cancers
Disease control OngoingThis early-stage trial is testing whether combining an experimental cancer drug called MK-2206 with the malaria drug hydroxychloroquine is safe for people with advanced solid tumors, melanoma, kidney, or prostate cancer. The main goal is to find the highest dose patients can tole…
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New combo therapy tested to stall prostate Cancer's return
Disease control OngoingThis study is for men whose prostate cancer is starting to come back, shown by a rising PSA level, after their initial surgery or radiation. It compares two treatment plans: one uses a standard hormone-blocking drug (bicalutamide) alone, and the other combines that drug with an e…
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC